You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 14, 2025

Drug Price Trends for FT ALLERGY (DIPHEN)


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for FT ALLERGY (DIPHEN)

Average Pharmacy Cost for FT ALLERGY (DIPHEN)

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
FT ALLERGY (DIPHEN) 25 MG TAB 70677-1014-01 0.03643 EACH 2025-01-22
FT ALLERGY (DIPHEN) 25 MG TAB 70677-1238-01 0.03643 EACH 2025-01-22
FT ALLERGY (DIPHEN) 25 MG CHEW 70677-1059-01 0.28050 EACH 2025-01-22
FT ALLERGY (DIPHEN) 25 MG CAP 70677-1015-01 0.04248 EACH 2025-01-22
FT ALLERGY (DIPHEN) 25 MG CAP 70677-1015-02 0.04248 EACH 2025-01-22
FT ALLERGY (DIPHEN) 25 MG CAP 70677-1015-01 0.04118 EACH 2024-12-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Diphenhydramine (FT ALLERGY)

Market Size and Growth Projections

The diphenhydramine market, which includes products like FT ALLERGY, is anticipated to experience steady growth over the coming years. As of 2024, the market size is estimated to be around USD 0.99 billion, with projections indicating it will reach USD 1.10 billion by 2029, growing at a Compound Annual Growth Rate (CAGR) of 2.30% during the forecast period[1][3].

By 2030, the market is expected to expand further, reaching approximately USD 1.13 billion, maintaining a CAGR of 2.3% from 2025 to 2030[1][3].

Key Drivers of Market Growth

Increasing Prevalence of Allergies

The rising number of people suffering from seasonal allergies and allergic rhinitis is a significant driver of the market. For instance, about 25.7% of US adults reported experiencing seasonal allergies in 2022, and it is projected that by 2025, around 50% of Europe's population will suffer from some type of allergy sensitivity due to climate change[1][3].

Growing Demand for OTC Medications

The convenience and accessibility of over-the-counter (OTC) medications like diphenhydramine are boosting market growth. The availability of diphenhydramine without a prescription makes it a preferred choice for managing mild allergic reactions, cold symptoms, and other related conditions[1][5].

Motion Sickness and Insomnia

The increasing prevalence of motion sickness among international travelers and the growing awareness about sleep disorders are also driving the demand for diphenhydramine. For example, an estimated 66.5 million tourists traveled internationally in the United States in 2023, a 31% increase from 2022, which increases the risk of motion sickness and subsequently the demand for diphenhydramine[1][3].

Environmental Factors

Rising pollution levels and changing environmental conditions are contributing to an increase in allergic reactions, further propelling the demand for antihistamines like diphenhydramine. Approximately 131 million Americans were exposed to unhealthy levels of ozone and particle pollution in 2024, marking an increase of 11.7 million from 2023[1][3].

Price Projections

Current Trends

Diphenhydramine hydrochloride prices are expected to rise moderately on a global scale, driven by steady demand from the pharmaceutical and healthcare sectors, coupled with constrained supply. Seasonal changes, such as the onset of allergy season, further drive this trend, leading manufacturers and suppliers to adjust prices accordingly[2].

Supply Chain and Market Dynamics

The upcoming holidays in China, such as the Mid-Autumn Festival and the Golden Week, are expected to influence market dynamics by causing production slowdowns, distribution interruptions, and supply chain disruptions. This could temporarily constrain the availability of diphenhydramine hydrochloride, putting upward pressure on its prices[2].

Economic Factors

Consumer sentiment and economic conditions also play a role in price projections. For instance, the increase in consumer confidence in the U.S. and the potential for monetary easing in Europe could support rising diphenhydramine hydrochloride prices. Additionally, heavy congestion at U.S. ports due to high import volumes is expected to sustain strong market demand, further supporting price hikes[2].

Regional Market Analysis

North America

North America is anticipated to hold a significant share of the market due to the increasing number of allergic individuals and growing government initiatives. For example, around 25 metropolitan areas in the U.S. are under the high-risk category for allergy attacks, according to the Asthma and Allergy Foundation of America[1][3].

Challenges and Restraints

Side Effects

Despite the growth prospects, the side effects associated with diphenhydramine, such as drowsiness and potential interactions with other medications, are likely to hinder market growth. These side effects may lead to a preference for alternative treatments, especially among health-conscious consumers[1][3].

Regulatory Requirements

Stringent regulatory requirements also pose challenges to market players. Ensuring compliance with these regulations can be costly and time-consuming, potentially affecting the market's overall growth[5].

Technological Advancements and Innovations

The market is witnessing expansion fueled by technological advancements and innovations in drug delivery systems. Manufacturers are focusing on developing novel formulations to enhance the efficacy and duration of action of diphenhydramine-based products, thus widening its application spectrum[5].

Segment Analysis

The global diphenhydramine market is segmented based on dosage forms, including tablets, injections, powders, and syrups, which offer diverse options for patients and healthcare providers. Allergies remain a significant segment propelling market growth, while the demand for diphenhydramine in treating insomnia and alleviating cold symptoms is also projected to surge[5].

Key Takeaways

  • The diphenhydramine market is expected to grow from USD 0.99 billion in 2024 to USD 1.10 billion by 2029.
  • Key drivers include the increasing prevalence of allergies, motion sickness, and insomnia, as well as growing demand for OTC medications.
  • Price projections indicate moderate increases due to steady demand and constrained supply.
  • North America is expected to hold a significant market share.
  • Side effects and regulatory requirements are potential restraints on market growth.
  • Technological advancements are expanding the application spectrum of diphenhydramine.

FAQs

Q: What is the projected market size of the diphenhydramine market by 2029? A: The diphenhydramine market is expected to reach USD 1.10 billion by 2029[1][3].

Q: What are the main drivers of the diphenhydramine market growth? A: The main drivers include the increasing prevalence of allergies, growing demand for OTC medications, motion sickness, and insomnia, as well as environmental factors like pollution and climate change[1][3][5].

Q: Why are diphenhydramine hydrochloride prices expected to rise? A: Prices are expected to rise due to steady demand, constrained supply, and seasonal changes, as well as supply chain disruptions and economic factors[2].

Q: Which region is expected to hold a significant share of the diphenhydramine market? A: North America is anticipated to hold a significant share due to the increasing number of allergic individuals and growing government initiatives[1][3].

Q: What are the potential challenges to the diphenhydramine market growth? A: The side effects associated with diphenhydramine and stringent regulatory requirements are potential challenges to market growth[1][3][5].

Sources

  1. Mordor Intelligence - Diphenhydramine Market Size & Share Analysis
  2. ChemAnalyst - Allergy Season Squeeze: Diphenhydramine Hydrochloride Prices Set to Soar in September
  3. Mordor Intelligence - Diphenhydramine Market Size (2024 - 2029)
  4. Morningstar - Allergy Therapeutics forecasts revenue drop but trials going well
  5. Reanin - Global Diphenhydramine Market | Growth | Share | Size | Trends and Forecast

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.